358 related articles for article (PubMed ID: 23025847)
1. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
2. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure.
Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ
Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191
[TBL] [Abstract][Full Text] [Related]
3. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
4. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-α-peptide architecture.
Richman M; Wilk S; Chemerovski M; Wärmländer SK; Wahlström A; Gräslund A; Rahimipour S
J Am Chem Soc; 2013 Mar; 135(9):3474-84. PubMed ID: 23360549
[TBL] [Abstract][Full Text] [Related]
5. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
6. De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors.
Wang Q; Liang G; Zhang M; Zhao J; Patel K; Yu X; Zhao C; Ding B; Zhang G; Zhou F; Zheng J
ACS Chem Neurosci; 2014 Oct; 5(10):972-81. PubMed ID: 25133634
[TBL] [Abstract][Full Text] [Related]
7. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
8. Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates.
Sörgjerd KM; Zako T; Sakono M; Stirling PC; Leroux MR; Saito T; Nilsson P; Sekimoto M; Saido TC; Maeda M
Biochemistry; 2013 May; 52(20):3532-42. PubMed ID: 23614719
[TBL] [Abstract][Full Text] [Related]
9. Selection of peptide inhibitors of soluble Aβ(1-42) oligomer formation by phage display.
Kawasaki T; Onodera K; Kamijo S
Biosci Biotechnol Biochem; 2010; 74(11):2214-9. PubMed ID: 21071869
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
11. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
[TBL] [Abstract][Full Text] [Related]
12. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
13. A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.
Nakagami Y; Nishimura S; Murasugi T; Kaneko I; Meguro M; Marumoto S; Kogen H; Koyama K; Oda T
Br J Pharmacol; 2002 Nov; 137(5):676-82. PubMed ID: 12381681
[TBL] [Abstract][Full Text] [Related]
14. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
15. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
[TBL] [Abstract][Full Text] [Related]
16. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
17. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
18. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
[TBL] [Abstract][Full Text] [Related]
19. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation.
Wasiak T; Ionov M; Nieznanski K; Nieznanska H; Klementieva O; Granell M; Cladera J; Majoral JP; Caminade AM; Klajnert B
Mol Pharm; 2012 Mar; 9(3):458-69. PubMed ID: 22206488
[TBL] [Abstract][Full Text] [Related]
20. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
